BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8879960)

  • 1. Absence of the Gly40-ser mutation in the glucagon receptor gene in Japanese subjects with NIDDM.
    Ogata M; Iwasaki N; Ohgawara H; Karibe S; Omori Y
    Diabetes Res Clin Pract; 1996 Jul; 33(2):71-4. PubMed ID: 8879960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of association between the Gly40-->Ser mutation in the human glucagon receptor and Japanese patients with non-insulin-dependent diabetes mellitus or impaired glucose tolerance.
    Odawara M; Tachi Y; Yamashita K
    Hum Genet; 1996 Dec; 98(6):636-9. PubMed ID: 8931690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland.
    Huang X; Orho M; Lehto M; Groop L
    Diabetologia; 1995 Oct; 38(10):1246-8. PubMed ID: 8690179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population. The Sardinian Diabetes Genetic Study Group.
    Tonolo G; Melis MG; Ciccarese M; Secchi G; Atzeni MM; Maioli M; Pala G; Massidda A; Manai M; Pilosu RM; Li LS; Luthman H; Maioli M
    Diabetologia; 1997 Jan; 40(1):89-94. PubMed ID: 9028723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus.
    Fujisawa T; Ikegami H; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Ueda H; Fukuda M; Ogihara T
    Diabetologia; 1995 Aug; 38(8):983-5. PubMed ID: 7589886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the glucagon receptor gene and non-insulin-dependent diabetes mellitus in the Russian population.
    Babadjanova G; Reincke M; Mora P; Chuchalin A; Allolio B
    Exp Clin Endocrinol Diabetes; 1997; 105(4):225-6. PubMed ID: 9285210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Gly40Ser polymorphism in the glucagon receptor gene in a German non-insulin-dependent diabetes mellitus population.
    Ambrosch A; Lobmann R; Dierkes J; König W; Luley C; Lehnert H
    Clin Chem Lab Med; 1999 Jul; 37(7):719-21. PubMed ID: 10510728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restricted geographical extension of the association of a glucagon receptor gene mutation (Gly40Ser) with non-insulin-dependent diabetes mellitus.
    Ristow M; Busch K; Schatz H; Pfeiffer A
    Diabetes Res Clin Pract; 1996 May; 32(3):183-5. PubMed ID: 8858207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gly40Ser mutation of glucagon receptor gene and NIDDM in Han nationality].
    Deng H; Tang WL; Pan Q
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):291-3. PubMed ID: 12536714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codon 972 polymorphism of the insulin receptor substrate-1 gene in impaired glucose tolerance and late-onset NIDDM.
    Yamada K; Yuan X; Ishiyama S; Shoji S; Kohno S; Koyama K; Koyanagi A; Koyama W; Nonaka K
    Diabetes Care; 1998 May; 21(5):753-6. PubMed ID: 9589236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus.
    Hager J; Hansen L; Vaisse C; Vionnet N; Philippi A; Poller W; Velho G; Carcassi C; Contu L; Julier C
    Nat Genet; 1995 Mar; 9(3):299-304. PubMed ID: 7773293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of the Trp 64 Arg mutation of the beta3-adrenergic receptor gene in impaired glucose tolerance, non-insulin-dependent diabetes mellitus, and insulin resistance in Japanese subjects.
    Azuma N; Yoshimasa Y; Nishimura H; Yamamoto Y; Masuzaki H; Suga J; Shigemoto M; Matsuoka N; Tanaka T; Satoh N; Igaki T; Miyamoto Y; Itoh H; Yoshimasa T; Hosoda K; Nishi S; Nakao K
    Metabolism; 1998 Apr; 47(4):456-60. PubMed ID: 9550545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of the Gly40-Ser mutation in the glucagon receptor among diabetic patients in the Netherlands.
    Hart LM; Stolk RP; Jansen JJ; Grobbee DE; Lemkes HH; Maassen JA
    Diabetes Care; 1995 Oct; 18(10):1400-1. PubMed ID: 8721949
    [No Abstract]   [Full Text] [Related]  

  • 14. [Human glucagon-like peptide-1 receptor gene in NIDDM].
    Tanizawa Y; Kaku K
    Nihon Rinsho; 1994 Oct; 52(10):2731-6. PubMed ID: 7983806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gly40Ser substitution in the glucagon receptor is rarely involved in the pathogenesis of NIDDM in Japanese patients.
    Odawara M; Matsunuma A; Yamashita K
    Diabetes Care; 1996 May; 19(5):547. PubMed ID: 8732726
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance.
    Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Mykkänen L; Deeb SS
    Diabetes Care; 1995 Mar; 18(3):398-400. PubMed ID: 7555485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA polymorphisms of the insulin receptor gene in Japanese subjects with non-insulin-dependent diabetes mellitus.
    Li SR; Oelbaum RS; Stocks J; Galton DJ
    Hum Hered; 1988; 38(5):273-6. PubMed ID: 2906902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean community.
    Costa A; Rios M; Casamitjana R; Gomis R; Conget I
    Diabetes Res Clin Pract; 1998 Sep; 41(3):191-6. PubMed ID: 9829348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
    Zhang Y; Wat N; Stratton IM; Warren-Perry MG; Orho M; Groop L; Turner RC
    Diabetologia; 1996 Dec; 39(12):1505-11. PubMed ID: 8960833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population association study of four candidate genes (hexokinase II, glucagon-like peptide-1 receptor, fatty acid binding protein-2, and apolipoprotein C-II) with type 2 diabetes and impaired glucose tolerance in Japanese subjects.
    Yagi T; Nishi S; Hinata S; Murakami M; Yoshimi T
    Diabet Med; 1996 Oct; 13(10):902-7. PubMed ID: 8911786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.